Quicksilver II Pilot Study
NCT07688135
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Stage II Rectal Cancer
Stage III Rectal Cancer
Interventions
PROCEDURE:
Direct-to-surgery (i.e., no neoadjuvant chemotherapy)
PROCEDURE:
Control Group
Sponsor
Mount Sinai Hospital, Canada